Financials
- Market Capitalization 215.09 M
- Employee 288
- Founded 2009
- CEO Kevin Lee
- Website www.bicycletherapeutics.com
- Headquarter United Kingdom
- FIGI BBG00P0YWPK6
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-1.47
Rapporto prezzo/fatturato
5.06
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 3587 | DTIL Precision BioSciences, Inc. - Common Stock | 8.85 USD | +3.03% | -1.67% | +43.20% | +92.39% | 228.35 M USD | ||
| 3590 | KROS Keros Therapeutics, Inc. - common stock | 10.88 USD | -1.98% | -2.77% | +5.12% | -27.95% | 215.34 M USD | ||
| 3597 | CGEN Compugen Ltd. - Ordinary Shares | 2.28 USD | -0.87% | -5.00% | +12.32% | +41.61% | 215.58 M USD | ||
| 3598 | CLLS Cellectis S.A. - American Depositary Shares | 2.97 USD | +2.77% | -7.19% | -4.19% | +29.13% | 213.10 M USD |